Two Sigma Investments
ONC

Two Sigma Investments’s BeOne Medicines Ltd ONC Stock Holding History

Two Sigma Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.96M Buy
33,543
+25,143
+299% +$8.14M 0.01% 1413
2025
Q4 		$2.55M Buy
+8,400
New +$2.75M ﹤0.01% 2265
2025
Q2 		– Sell
-104,466
Closed -$28.4M – 3639
2025
Q1 		$28.4M Buy
+104,466
New +$24.4M 0.06% 372

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Investments's ONC Position: Q1 2026 in Review

Two Sigma Investments increased its BeOne Medicines Ltd (ONC) stake by 299% in Q1 2026, buying an estimated $8.14M and bringing the position to 33,543 shares worth $9.96M. The position accounts for 0.01% of the portfolio, ranked #1413.

Two Sigma Investments first reported a position in ONC in Q1 2025 and has held it in 3 quarters since. The position peaked at $28.4M in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Two Sigma Investments held 33,543 shares of BeOne Medicines Ltd worth $9.96M as of Q1 2026.
  • Two Sigma Investments bought 25,143 BeOne Medicines Ltd shares in Q1 2026, an estimated $8.14M.
  • BeOne Medicines Ltd made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1413 holding.
  • Two Sigma Investments first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 3 quarters since.
  • Two Sigma Investments's BeOne Medicines Ltd position peaked at $28.4M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.